Literature DB >> 1554969

The role of calcium antagonists in the treatment of cerebrovascular disease.

J J Murphy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1554969     DOI： 10.2165/00002512-199202010-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  36 in total

1.  Animal models of stroke: are they relevant to human disease?

Authors:  D O Wiebers; H P Adams; J P Whisnant
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

Review 2.  Animal stroke models. They are relevant to human disease.

Authors:  J A Zivin; J C Grotta
Journal:  Stroke       Date:  1990-07       Impact factor: 7.914

3.  Safety and efficacy of nimodipine in resuscitation of patients outside hospital.

Authors:  R O Roine; M Kaste; A Kinnunen; P Nikki
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

4.  Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery.

Authors:  O B Paulson
Journal:  Neurology       Date:  1970-01       Impact factor: 9.910

5.  Double-blind study of nimodipine in non-severe stroke.

Authors:  J Bogousslavsky; F Regli; V Zumstein; W Köbberling
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

6.  Pial arterial and venous reaction to intravenous infusion of nimodipine in cats.

Authors:  L M Auer
Journal:  J Neurosurg Sci       Date:  1982 Jul-Sep       Impact factor: 2.279

7.  Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.

Authors:  R O Roine; M Kaste; A Kinnunen; P Nikki; S Sarna; S Kajaste
Journal:  JAMA       Date:  1990-12-26       Impact factor: 56.272

8.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

9.  Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat.

Authors:  O Gotoh; A A Mohamed; J McCulloch; D I Graham; A M Harper; G M Teasdale
Journal:  J Cereb Blood Flow Metab       Date:  1986-06       Impact factor: 6.200

10.  Nimodipine in acute ischemic stroke: a double-blind controlled study.

Authors:  A Paci; P Ottaviano; A Trenta; G Iannone; L De Santis; G Lancia; E Moschini; M Carosi; S Amigoni; L Caresia
Journal:  Acta Neurol Scand       Date:  1989-10       Impact factor: 3.209
View more
  3 in total

Review 1.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

Review 2.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 3.  Nimodipine. Potential for drug-drug interactions in the elderly.

Authors:  W Mück; G Ahr; J Kuhlmann
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.